RIVUR Clinical Trial
$15,750Y01FY2010DKNIH
National Institute Of Diabetes And Digestive And Kidney Diseases
Investigators
Abstract
This study is a randomized, double-blind, placebo-controlled trial of the trimethoprim sulfamethoxazole (TMP/SMZ) suspension in children with vesicoureteral reflux. The study is designed to recruit 600 children (approximately 300 in each treatment group) and follow them 24 months.
View original record on NIH RePORTER →